Validation of High-Sensitivity Severe Acute Respiratory Syndrome Coronavirus 2 Testing for Stool—Toward the New Normal for Fecal Microbiota Transplantation

INTRODUCTION: Mounting evidence demonstrates potential for fecal–oral transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The US Food and Drug Administration now requires SARS-CoV-2 testing of potential feces donors before the use of stool manufactured for fecal microbiota...

Descripción completa

Detalles Bibliográficos
Autores principales: Babiker, Ahmed, Ingersoll, Jessica M., Adelman, Max W., Webster, Andrew S., Broder, Kari J., Stittleburg, Victoria, Waggoner, Jesse J., Kraft, Colleen S., Woodworth, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189625/
https://www.ncbi.nlm.nih.gov/pubmed/34106090
http://dx.doi.org/10.14309/ctg.0000000000000363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189625/
https://www.ncbi.nlm.nih.gov/pubmed/34106090
http://dx.doi.org/10.14309/ctg.0000000000000363

Ejemplares similares